FDA Approves First-of-Its-Kind Drug for Polycythemia Vera, Sparing Patients Frequent Blood Draws
FDA Approves First-of-Its-Kind Drug for Polycythemia Vera, Sparing Patients Frequent Blood Draws The Food and Drug Administration approved Mimrylo (rusfertide) on Friday, August 28, the first drug of its kind for polycythemia vera, a rare blood disorder that causes the body to produce dangerously excessive amounts of red blood cells. The approval gives patients a … Read more